Nu Skin Enterprises (NYSE:NUS - Get Free Report) released its quarterly earnings results on Thursday. The company reported $0.43 EPS for the quarter, topping the consensus estimate of $0.25 by $0.18, Zacks reports. The business had revenue of $386.14 million for the quarter, compared to analysts' expectations of $376.68 million. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%. Nu Skin Enterprises updated its FY 2025 guidance to 1.150-1.350 EPS.
Nu Skin Enterprises Price Performance
Shares of NYSE:NUS traded up $0.40 during trading on Wednesday, reaching $11.55. The stock had a trading volume of 227,808 shares, compared to its average volume of 655,294. The business's 50-day moving average price is $8.50 and its 200 day moving average price is $7.53. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.01 and a quick ratio of 1.38. Nu Skin Enterprises has a 52 week low of $5.32 and a 52 week high of $11.96. The stock has a market capitalization of $570.44 million, a PE ratio of 5.78 and a beta of 0.91.
Nu Skin Enterprises Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 10th. Stockholders of record on Friday, August 29th will be paid a $0.06 dividend. The ex-dividend date is Friday, August 29th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 2.1%. Nu Skin Enterprises's payout ratio is 11.94%.
Insiders Place Their Bets
In other Nu Skin Enterprises news, Director Edwina D. Woodbury sold 4,532 shares of the business's stock in a transaction dated Monday, June 2nd. The shares were sold at an average price of $8.44, for a total transaction of $38,250.08. Following the sale, the director directly owned 42,947 shares of the company's stock, valued at $362,472.68. The trade was a 9.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, insider Steven Keith Hatchett purchased 6,500 shares of the business's stock in a transaction on Wednesday, May 28th. The shares were acquired at an average cost of $7.54 per share, for a total transaction of $49,010.00. Following the completion of the transaction, the insider directly owned 162,065 shares in the company, valued at approximately $1,221,970.10. This represents a 4.18% increase in their ownership of the stock. The disclosure for this purchase can be found here. 2.00% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Large investors have recently bought and sold shares of the stock. Amundi boosted its position in shares of Nu Skin Enterprises by 18.8% during the 1st quarter. Amundi now owns 18,564 shares of the company's stock worth $127,000 after acquiring an additional 2,941 shares in the last quarter. Dynamic Technology Lab Private Ltd acquired a new position in shares of Nu Skin Enterprises during the first quarter valued at about $162,000. Russell Investments Group Ltd. grew its holdings in shares of Nu Skin Enterprises by 18.5% during the second quarter. Russell Investments Group Ltd. now owns 20,405 shares of the company's stock valued at $163,000 after buying an additional 3,179 shares during the last quarter. Rhumbline Advisers boosted its holdings in Nu Skin Enterprises by 3.7% during the second quarter. Rhumbline Advisers now owns 80,119 shares of the company's stock worth $640,000 after purchasing an additional 2,856 shares during the last quarter. Finally, AQR Capital Management LLC boosted its stake in Nu Skin Enterprises by 64.6% in the first quarter. AQR Capital Management LLC now owns 350,357 shares of the company's stock valued at $2,530,000 after acquiring an additional 137,475 shares during the last quarter. 82.84% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Separately, Wall Street Zen lowered Nu Skin Enterprises from a "strong-buy" rating to a "buy" rating in a report on Saturday.
View Our Latest Stock Report on Nu Skin Enterprises
Nu Skin Enterprises Company Profile
(
Get Free Report)
Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.
See Also

Before you consider Nu Skin Enterprises, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nu Skin Enterprises wasn't on the list.
While Nu Skin Enterprises currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.